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Abstract
Despite the availability of combination antiretroviral therapy, at least mild cognitive dysfunction is
commonly observed in HIV-infected patients, with an estimated prevalence of 35-70%.
Neuropsychological studies of these HIV-associated neurocognitive disorders (HAND) have
documented aberrations across a broad range of functional domains, although the basic
pathophysiology remains unresolved. Some of the most common findings have been deficits in
fine motor control and reduced psychomotor speed, but to date no neuroimaging studies have
evaluated basic motor control in HAND. In this study, we used magnetoencephalography (MEG)
to evaluate the neurophysiological processes that underlie motor planning in older HIV-infected
adults and a matched, uninfected control group. MEG is a noninvasive and direct measure of
neural activity with good spatiotemporal precision. During the MEG recording, participants
fixated on a central crosshair and performed a finger-tapping task with the dominant hand. All
MEG data was corrected for head movements, preprocessed, and imaged in the time-frequency
domain using beamforming methodology. All analyses focused on the pre-movement beta
desynchronization, which is known to be an index of movement planning. Our results
demonstrated that HIV-1-infected patients have deficient beta desynchronization relative to
controls within the left/right precentral gyri, and the supplementary motor area. In contrast, HIV-
infected persons showed abnormally strong beta responses compared to controls in the right
dorsolateral prefrontal cortex and medial prefrontal areas. In addition, the amplitude of beta
activity in the primary and supplementary motor areas correlated with scores on the Grooved
Pegboard test in HIV-infected adults. These results demonstrate that primary motor and sensory
regions may be particularly vulnerable to HIV-associated damage, and that prefrontal cortices may
serve a compensatory role in maintaining motor performance levels in infected patients.
Corresponding Author: Tony W. Wilson, Ph.D. Center for Magnetoencephalography Department of Pharmacology & Experimental
Neuroscience University of Nebraska Medical Center 988422 Nebraska Medical Center Omaha, NE 68198 Phone: (402) 552-6431
Fax: (402) 559-5747 Tony.W.Wilson@gmail.com.
The authors declare that they have no conflict of interest.
NIH Public Access
Author Manuscript
J Neuroimmune Pharmacol. Author manuscript; available in PMC 2014 September 01.
Published in final edited form as:














HAND; cognitive disorders; biomarker; AIDS; MEG; beta ERD
Introduction
Since the availability of potent combination antiretroviral therapy (cART), the nature of
human immunodeficiency virus type one (HIV) infection has dramatically shifted from a
terminal illness to a chronic manageable condition. Nonetheless, overall life expectancy still
remains 10-30 years less than that of seronegative persons (Antiretroviral Therapy Cohort
Collaboration 2008; Deeks 2009), and infected patients remain at an increased risk of
developing HIV-associated neurocognitive disorders (HAND; Gannon et al. 2011; Heaton et
al. 2010, 2011; Sacktor et al. 2002; Simioni et al. 2010). Recent studies have shown that
35-70% of all HIV-infected patients (treated and untreated) are at least subtly impaired on
neuropsychological assessments of cognitive performance (Cysique and Brew 2009; Gannon
et al. 2011; Heaton et al. 2010, 2011; Simioni et al. 2010; Tozzi et al. 2007). Although the
overwhelming majority of these patients suffer from milder forms of HAND, as cART has
sharply decreased the prevalence of the more severe HIV-associated dementia (HAD;
Antinori et al. 2007; Cysique and Brew 2009; Dore et al. 2003; Heaton et al. 2010, 2011;
Robertson et al. 2007).
While neuropsychological studies have documented abnormalities across a broad range of
functional domains, deficits in fine motor control and reduced psychomotor speed have been
some of the most common findings in HAND (Cysique and Brew 2009; Hardy and Vance
2009; Joska et al. 2010; Robertson et al. 2009; Woods et al. 2009). In fact, this was partially
reflected in the original nomenclature, which included diagnostic categories for HAD (3
subtypes) and a less severe condition termed minor cognitive motor disorder (MCMD;
Janssen et al., 1991). The MCMD category was phased out in 2007 with the adoption of the
current classification system, which includes HAD, mild neurocognitive impairment, and
asymptomatic cognitive impairment (Antinori et al., 2007). Nonetheless, motor-related
deficits remain a critical problem in HIV-infected patients and are an essential feature of
HAND assessment (Mind Exchange Working Group 2013). The Trail Making Test, Color
Trails Test Part 2, Finger Tapping Test, and/or the Grooved Pegboard Test are the most
commonly employed motor assessments (Joska 2010; Robertson et al. 2009), with outcome
measures that include total completion time (for the test), average tapping rate for each
hand, total pegs placed, and related measures. HIV-infected patients typically exhibit
prolonged completion times (e.g., in Trail Making and Color Trails Tests) and lower average
tapping rates compared to age- and often culture-based normative data (Joska 2010; Mind
Exchange Working Group 2013; Robertson et al. 2009). Thus, while these tests are
relatively sensitive to deficits in function, they provide only limited information on the
nature of the deficit and lack specificity in regards to the neural bases of observed
impairments. For example, non-motor issues like abnormal executive functioning can
sharply decrease performance on measures of motor coordination and psychomotor speed,
and ultimately masquerade as a pure motor deficit in the absence of extensive
neuropsychological testing.
In the current study, we investigated the neural regions serving motor control in a group of
aging HIV-infected patients and a matched-group of uninfected controls using
magnetoencephalography (MEG). MEG is a noninvasive neurophysiological imaging
method that quantifies the minute magnetic fields that naturally emanate from populations of
active neural cells in the neocortex. The method has excellent temporal resolution and good
spatial precision, which allows neural activity serving individual movements to be
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decomposed into planning, execution, and termination stages. In healthy participants, these
different stages are represented by three distinct neural responses that have been widely
studied (Cheyne et al. 2008; Gaetz et al. 2010, 2011; Jurkiewicz et al. 2006; Tzagarakis et al.
2010; Wilson et al. 2010, 2011). Briefly, there is an event-related desynchronization (ERD)
in the beta-frequency range (14-28 Hz) that peaks before movement onset and continues
slightly afterward, which is termed the pre-movement beta ERD response. There is an event-
related synchronization (ERS) in the gamma-frequency range that coincides with the
movement onset and is very brief (i.e., 200 ms), and finally there is a post-movement beta
ERS that reaches maximum amplitude slightly after the termination of movement (Cheyne
et al. 2008; Gaetz et al. 2010, 2011; Jurkiewicz et al. 2006; Tzagarakis et al. 2010; Wilson et
al. 2010, 2011). This latter response is generally termed the post-movement beta rebound
(PMBR). For clarity, the frequency range (e.g., beta-band) of these responses merely
indicates the dominant neuronal firing rate across the population of neurons that generates
the specific response.
Our primary goal in the current study was to identify the critical brain regions and neural
processes that underlie the altered fine motor control and psychomotor speed typically seen
in HIV-infected persons. To this end, we investigated an older population of patients
comprised of both cognitively impaired and unimpaired persons according to the Frascati
criteria (Antinori et al. 2007). During the MEG recording session, participants performed a
MEG-compatible version of the finger tapping task with their dominant hand. We focused
on an older group of patients (i.e., ~60 years-old) because HIV-infected persons are living
much longer in the cART era (Hardy and Vance, 2009), and these patients may be
underrepresented in research studies. Moreover, we included a mix of mildly impaired and
non-impaired patients in order to capture the spectrum, while avoiding patients with severe
motor deficits so that behavioral performance (e.g., accuracy) could be standardized during
the MEG experiment. This standardization provided an important control for group
comparisons, as significant performance differences alone can produce activation
differences. No previous functional neuroimaging studies have evaluated motor activity in
HIV-infected patients, although one structural imaging study reported significant cortical
thinning in the primary motor, sensory, and premotor regions of patients relative to matched
controls (Thompson et al. 2005). Based on these findings and our past MEG studies of
motor control, we hypothesized that HIV-infected patients would show abnormally reduced
pre-movement beta ERD activation in primary motor regions (e.g., precentral gyri), and that
the amplitude of this activity would be significantly correlated with CD4+ T-cell counts and
neuropsychological measures of motor performance in the patient group.
Methods
We evaluated 12 HIV-infected adults (9 males) and 12 uninfected matched controls (9
males). Participants in the control group were individually-matched to patients in the HIV-
infected group in regards to age, sex, ethnicity, and handedness. Exclusionary criteria
included any pre-existing major psychiatric or neurological disorder, active brain infection
(except for HIV-1), presence of brain neoplasm or space-occupying lesion, history of head
trauma, current substance abuse, and the MEG Laboratory’s standard exclusion criteria (e.g.,
orthodontic braces, extensive dental work, ferromagnetic implants, etc.). The study was
approved by the University of Nebraska Medical Center Institutional Review Board and all
participants gave written informed consent.
Neuropsychological Assessments
All patients underwent neuropsychological testing prior to the MEG recording session. The
neuropsychological battery tested multiple domains and was designed to adhere to the
recommendations of the Frascati consensus (Antinori et al. 2007). The assessed functional
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domains included gross and fine motor, language, verbal learning, verbal memory, speed of
information processing, attention and working memory, and executive functioning.
Correlation analyses were conducted on the MEG data and a selection of individual
neuropsychological tests, including the Grooved Pegboard and Trail Making Test B, which
are known to assess fine motor control and psychomotor speed and thus, were especially
relevant to our primary hypotheses.
Experimental Paradigm
Throughout the movement task, participants were seated within the magnetically-shielded
room with both arms resting in front of them on a tray attached to the chair body.
Participants were instructed to fixate on a centrally-presented cross hair and to perform a
single knuckle flexion-extension, using the right index finger, each time a dot reached the 12
o’clock position. This dot completed one full revolution, around a clock-like circle without
tick marks or numbers, every 6 s (see Figure 1A) and was meant to serve as a pacing device.
The precise timing of movement onset was determined by a laser beam system (see Figure
1B), whereby the initiation of movement interrupted a laser beam that extended across a
groove, designed to be the finger landing area at the completion of each tap. This disruption
of the laser beam functioned to break an electrical circuit, which caused a TTL pulse to be
emitted. These TTL pulses were recorded, along with the MEG data, by the main acquisition
computer. Each participant performed approximately 120 trials and the total recording time
was ~11 min.
MEG Data Acquisition
All recordings were conducted in a one-layer magnetically-shielded room with active
shielding engaged for advanced environmental noise compensation. During data acquisition,
participants were monitored via real-time audio-video feeds from inside the shielded room.
With an acquisition bandwidth of 0.1 – 330 Hz, neuromagnetic responses were sampled
continuously at 1 kHz using an Elekta Neuromag system (Helsinki, Finland) with 306 MEG
sensors, including 204 planar gradiometers and 102 magnetometers. Using the MaxFilter
software (Elekta), each MEG data set was individually corrected for head motion during
task performance and subjected to noise reduction using the signal space separation method
with a temporal extension (Taulu and Simola 2006; Taulu et al. 2005).
MEG Coregistration & Structural MRI Processing
Prior to MEG measurement, four coils were attached to the participant’s head and the
locations of these coils, together with the three fiducial points and scalp surface, were
determined with a 3-D digitizer (Fastrak 3SF0002, Polhemus Navigator Sciences,
Colchester, VT, USA). Once the participant was positioned for MEG recording, an electric
current with a unique frequency label (e.g., 322 Hz) was fed to each of the coils. This
induced a measurable magnetic field and allowed each coil to be localized in reference to the
sensors throughout the recording session. Since coil locations were also known in head
coordinates, all MEG measurements could be transformed into a common coordinate
system. With this coordinate system (including the scalp surface points), each participant’s
MEG data was coregistered with structural T1-weighted MRI data prior to source space
analyses. Structural MRI data were aligned parallel to the anterior and posterior
commissures and transformed into the Talairach coordinate system (Talairach and Tournoux
1988) using BrainVoyager QX (Brain Innovations, The Netherlands).
MEG Pre-Processing
Artifact rejection was based on a fixed threshold method, supplemented with visual
inspection. Epochs were of 5.0 s duration (−2.0 to 3.0 s), with 0.0 s defined as movement
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onset and the baseline being the −2.0 to −1.2 s time window. Artifact-free epochs were
transformed into the time-frequency domain using complex demodulation (resolution: 2.0
Hz, 25 ms; Hoechstetter et al. 2004; Papp and Ktonas 1977), and the resulting spectral
power estimations per sensor were averaged over trials to generate time-frequency plots of
mean spectral density.
MEG Source Imaging
Cortical networks were imaged through an extension of the linearly constrained minimum
variance vector beamformer (Gross et al. 2001), which employs spatial filters in the
frequency domain to calculate source power for the entire brain volume. The single images
are derived from the cross spectral densities of all combinations of MEG sensors averaged
over the time-frequency range of interest, and the solution of the forward problem for each
location on a grid specified by input voxel space. Following convention, the source power in
these images was normalized per subject using a separately averaged pre-stimulus noise
period of equal duration and bandwidth (van Veen et al. 1997). In principle, the beamformer
operator generates a spatial filter for each grid point, which passes signals without
attenuation from the given neural region while minimizing interference from activity in all
other brain areas. The properties of these filters are determined from the MEG covariance
matrix and the forward solution for each grid point in the image space, which are used to
allocate sensitivity weights to each sensor in the array for each voxel in the brain (for a
review, see Hillebrand et al. 2005).
Normalized source power was computed for the time-frequency range of interest (beta ERD:
14-28 Hz, −350 to 250 ms) over the entire brain volume per participant at 4.0 × 4.0 × 4.0
mm resolution. Each subject’s functional images, which were co-registered to anatomical
images prior to beamforming, were transformed into a standardized space (Talairach and
Tournoux 1988) using the transform previously applied to the structural MRI volume. MEG
pre-processing and imaging used the Brain Electrical Source Analysis (BESA version 5.3.2)
software, and MEG-MRI coregistration used the BrainVoyager QX (Version 2.2) software.
Given the primary objective and hypotheses of this study, all MEG data analyses were
focused on the pre-movement beta ERD response. This oscillatory response occurs within
the 14-28 Hz frequency range, and it begins and reaches peak amplitude before movement
onset, then dissipates slightly after movement commences. The other parameters of the beta
ERD are equally-well characterized, as several MEG studies of healthy controls were
recently conducted by our group and others (Cheyne et al. 2008; Gaetz et al. 2010;
Jurkiewicz et al. 2006; Tzagarakis et al. 2010; Wilson et al. 2010, 2011). Thus, we imaged
the beta ERD response (−350 to 250 ms, 14-28 Hz) using beamforming, and statistically
evaluated the resulting 3D maps of functional brain activity using a mass univariate
approach based on the general linear model. Briefly, the effect of group was examined using
a random effects analysis, whereas task effects were examined using one-sample t-tests in
each group. In both cases, the statistical parametric maps were initially thresholded and a
cluster-based correction method (i.e., 40 contiguous voxels) was applied to the supra-
threshold voxels to reduce the risk of false positive results.
Results
Participant Demographics, Blood Work, & Neuropsychological Measures
Mean age was 57.9 years-old (range: 50-69) in the HIV-infected group, and 58.3 years-old
(range: 50-70 years) in the control group. This difference did not approach significance. All
HIV-infected participants were receiving effective antiretroviral therapy and had
undetectable viremia during the study. The mean duration of HIV diagnosis was 17 years
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(range: 10-22), and the average CD4+ T-cell count was 741 cells/mm3 (range: 267-1276).
Of the 12 HIV-infected patients, six were impaired in at least two domains and thus were
considered impaired according to the Frascati criteria (Antinori et al. 2007); however, only
two of the twelve patients were impaired on tests of motor function.
MEG Task Effects
HIV-infected participants exhibited significant beta ERD responses near the hand knob
feature of the left precentral gyrus (Yousry et al. 1997), and this activity extended posterior
to include the central sulcus and left postcentral gyrus. These participants also exhibited
significant beta ERD in the right precentral gyrus (extending to the postcentral gyrus) and
the medial prefrontal cortices (all p’s < 0.001, cluster-corrected; see Figure 2). Uninfected
controls also had significant beta ERD responses centered near the motor hand knob feature
of the left precentral gyrus, which extended posterior to include aspects of the central sulcus
and left postcentral gyrus. In addition, significant beta ERD was found in the right precentral
gyrus and the supplementary motor area (SMA) of uninfected controls (all p’s < 0.001,
cluster-corrected; see Figure 2).
MEG Group Effects
Responses in the right dorsolateral prefrontal cortex (DLPFC), medial prefrontal cortices,
and a small area of the left inferior frontal gyrus were significantly stronger in HIV-infected
participants compared with controls (all p’s < 0.01; cluster-corrected; see Figure 3).
Conversely, beta ERD responses in the SMA and the left and right precentral gyri were
significantly stronger in healthy controls compared with HIV-infected participants (all p’s <
0.01, cluster-corrected; see Figure 3).
Neuropsychological, CD4, & MEG Correlations
To examine possible relationships between MEG measures of beta ERD, CD4 T-cell counts,
and neuropsychological metrics of fine motor control and psychomotor speed, we conducted
a series of Pearson-correlation analyses in the HIV-infected participants. To this end, we
used the maximum amplitude value in each brain region where group differences were
found, and the participant scores on individual neuropsychological assessments of fine
motor control (Grooved Pegboard: dominant-hand raw score) and psychomotor speed (Trail
Making Test A-B). Since these analyses were restricted to brain areas where significant
group differences were observed, we did not correct p-values for multiple comparisons (e.g.,
using the Bonferroni method).
These analyses showed that performance on the Grooved Pegboard task (raw score for the
dominant hand) was significantly correlated with the amplitude of beta ERD responses in
the left precentral gyrus, r(12) = 0.70 (p < 0.01, two-tailed) and the SMA, r(12) = 0.79 (p <
0.01, two-tailed), but not in other brain regions of HIV-infected participants (see Figure 4).
Performance on the Trail Making Test – A (HIV-infected participants) was significantly
correlated with response amplitude in the left inferior frontal gyrus, r(12) = 0.58 (p < 0.05,
two-tailed) and marginally in the right DLPFC, r(12) = 0.51 (p < 0.10, two-tailed).
Performance on the Trail Making Test – B was correlated with beta response amplitude in
the medial prefrontal cortices, r(12) = 0.66 (p < 0.05, two-tailed) and the right DLPFC, r(12)
= 0.75 (p < 0.01, two-tailed) in HIV-infected participants. Beta ERD amplitude in other
brain regions was not correlated with performance on the Trail Making Tests (A-B). Finally,
CD4+ T-cell counts at the time of MEG recording were negatively correlated with beta ERD
amplitude in the SMA, r(12) = −0.48 (p = 0.11, two-tailed), which indicates that patients
with the highest CD4 counts had the strongest beta ERD responses in the SMA (i.e., were
more like controls). However, this effect was only marginal and CD4 count did not correlate
Wilson et al. Page 6













with activity in other brain areas, or performance on neuropsychological measures of
psychomotor speed or fine motor control.
Discussion
Our most important findings were the sharply reduced beta ERD responses in the primary
motor cortices and the SMA of HIV-infected participants. Moreover, these reductions in key
regions for motor control were accompanied by significantly stronger responses in higher-
order brain centers, such as the right DLPFC and medial prefrontal cortices, which may
reflect some sort of compensatory mechanism in HIV-infected participants. The motor-
related beta ERD response, which begins and reaches peak amplitude before movement
onset, has been widely acknowledged as a marker of motor planning (e.g., Gaetz et al. 2010;
Jurkiewicz et al. 2006; Tzagarakis et al. 2010; Wilson et al. 2010, 2011) and would be an
obvious candidate for such compensatory processing. In addition, we found that activity in
these higher-order brain areas was correlated with performance on neuropsychological
measures of psychomotor speed, whereas assessments of fine motor control (i.e., Grooved
Pegboard) were more closely tied to beta ERD responses in the primary and supplementary
motor areas. Below, we discuss the implications of these findings for understanding the
neural circuitry of motor-related deficits in HIV-infected participants (Cysique and Brew
2009; Hardy and Vance 2009; Joska et al. 2010; Woods et al. 2009), and more generally for
neuroimaging studies of HAND.
Uninfected controls generated a strong beta ERD response slightly before movement onset
in the left and right primary motor cortex, and the SMA in this study. These results are
consistent with many prior studies of healthy adults and children (Gaetz et al. 2010;
Jurkiewicz et al. 2006; Tzagarakis et al. 2010; Wilson et al. 2010, 2011; among others),
which have characterized this response as a marker of movement planning. Compared with
controls, HIV-infected participants exhibited a similar beta ERD response, although its
magnitude was significantly diminished in primary motor cortices (bilaterally) and the
SMA. These results are consistent with recent reports that used functional magnetic
resonance imaging (fMRI) to investigate visual areas. Ances and colleagues (2009, 2010)
showed reduced activation in the primary visual cortices during a basic visual stimulation
task, and decreased resting cerebral-blood-flow to the same visual areas in a large group of
HIV-infected patients relative to a group of uninfected healthy controls (Ances et al. 2009,
2010). While the current observations pertain to the motor cortices, both primary visual and
primary motor areas are considered modality-specific, non-association areas and thus, share
at least some parallels. Furthermore, there is growing evidence that the distinction between
association and non-association cortices is vital to understanding HIV-related brain
abnormalities (Chang et al. 2004), as brain areas within each category exhibit a core pattern
of dysfunction (discussed below). Ances et al. (2010) also reported comparable
abnormalities in cognitively-impaired and unimpaired patients in visual regions, which is
conceptually supportive of our findings in a similarly mixed (i.e., cognitively-impaired and
un-impaired) HIV-infected sample. Essentially, we observed significant differences in the
core centers of motor control, yet our patients were unimpaired or only mildly impaired on
neuropsychological tests of motor function. We specifically focused on this group (i.e.,
mildly or unimpaired) to prevent performance differences from confounding our MEG
group comparisons. Interestingly, in the current study, the amplitude of beta ERD responses
in the left primary motor cortices and SMA of HIV-infected patients was significantly
correlated with neuropsychological assessments of fine motor control with the same
dominant hand. In other words, patients who performed the best on neuropsychological
measures of fine motor control also had the strongest beta ERD responses in the left primary
motor cortex and SMA. Thus, while MEG abnormalities may be detectable in
neuropsychologically “normal” patients, our data suggests that certain MEG indices scale
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with the severity of impairment. Future studies should examine the nature of this
relationship (e.g., linear, nonlinear) as it could be harnessed as a diagnostic marker.
In contrast to the pattern seen in primary motor areas, HIV-infected patients had stronger
beta responses compared with controls in the right DLPFC, medial prefrontal cortices, and
the left inferior frontal gyrus. Activation in these brain regions is not generally reported in
normative studies of finger-tapping (e.g., Cheyne et al. 2008; Gaetz et al. 2010, 2011;
Jurkiewicz et al. 2006; Tzagarakis et al. 2010; Wilson et al. 2010, 2011), which may indicate
that these regions serve an active compensatory role in HIV-infected patients. Essentially,
these participants had reduced motor planning responses in the primary motor cortices and
the SMA, yet they continued to perform normally on the finger-tapping task, which suggests
some sort of active compensatory mechanism was likely in place. Consistent with these data,
several fMRI studies have reported greater activation in the frontal and prefrontal cortices
during attention and working memory tasks in HIV-infected participants relative to
uninfected controls (Chang et al. 2001, 2004, 2008; Ernst et al. 2002, 2009). Additionally, a
few of these studies used parametric working memory tasks and showed that patients exhibit
larger increases in activation as a function of task difficulty (i.e., memory set size), with
performance remaining the same as that observed in uninfected controls (Chang et al. 2004,
2008; Ernst et al. 2009). In other words, task performance remained equal between patients
and controls, but the amplitude of neural responses in prefrontal cortices and other
association areas increased significantly more in HIV-infected patients as task difficulty
increased. This pattern clearly suggests that neural activity in the prefrontal cortices is
serving an active compensatory role, and that it may allow the HIV-infected patients to
maintain a high level of task performance. In contrast, Melrose et al. (2008) reported
decreased left prefrontal and left caudate activation during a picture sequencing task in HIV-
infected patients who had mild motor deficits relative to healthy controls. Patients in this
study, however, performed less accurately than controls (p = 0.07) in the picture sequencing
task (Melrose et al. 2008), which at least partially supports the notion that prefrontal hyper-
activation is compensatory in HIV-infected patients. Finally, a recent study of tissue
specimens suggested that downregulation of Type 2 dopamine receptor mRNA in prefrontal
regions may also serve a compensatory role in HIV-infection (Gelman et al. 2012). Such
downregulation in the prefrontal cortices was correlated with neuropsychological function in
several cognitive domains (including motor), and occurred primarily in HIV-infected
patients who were cognitively unimpaired, and not in patients with HIV-encephalitis or
significant neurocognitive impairments (Gelman et al. 2012). In the current study, activation
in the prefrontal cortices presumably reflects additional processing in HIV-infected patients,
and perhaps stronger or more direct modulation of movement generating centers in the
primary motor cortex. Since patients did not show a separate activation maxima in the SMA,
as controls did, the DLPFC may compensate for, or replace, SMA function by directly
interacting with the primary motor cortices. The notion that these higher-order brain centers
play a distinct role in task performance, from that of the primary and supplementary motor
areas, is supported by our neuropsychological data. Briefly, whereas performance on the
Grooved Pegboard correlated with activation in the left primary motor cortices and SMA,
performance on the Trail Making Test – Part B correlated with beta ERD amplitude in the
right DLPFC and medial prefrontal cortices. These findings suggest that neural activity in
prefrontal areas is more tightly linked to psychomotor speed, while that in primary motor
cortex and the SMA is more closely connected to fine motor control. However, this
distinction should be understood as a gradient, and presumably all of these brain areas
contribute to all aspects of motor performance. Lastly, it is worth noting that we recently
observed abnormal activation in the frontal-eye fields of HIV-infected patients during a
visual processing task (unpublished data). The frontal-eye fields overlap and are spatially
contiguous with the SMA, which may suggest that this brain region is especially affected in
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HIV-infection. The SMA was also the only brain region in the current study where the peak
activation amplitude was marginally correlated with CD4+ cell counts.
More broadly, the current study has several parallels with neurophysiological findings in the
human electroencephalography (EEG) and monkey SIV (simian immunodeficiency virus)
literature. Many early EEG studies showed that the amplitude of the P300 event-related
potential was abnormally reduced in HIV-infected patients (Arendt et al. 1993; Egan et al.
1993; Fein et al. 1995; Goodin et al. 1990; Ollo et al. 1991). The P300 is thought to reflect
attention and working memory processes (Johnson 1988; Polich 1998), and is sensitive to
dementia (Polich et al. 1986, 1990). A more recent EEG study confirmed these P300
findings and found that oscillatory activity in the delta, theta, and global band (1-70 Hz) was
significantly stronger in the frontal electrodes of HIV-infected patients compared with
healthy controls, while alpha activity was abnormally reduced in the central-parietal
electrodes of the same patients (Polich et al. 2000). These data are largely consistent with
our findings of stronger frontal activity and weaker central-parietal activity in HIV-infected
patients, although we focused on the beta-band and the findings of Polich et al. (2000) were
mostly restricted to alpha and lower bands. One caveat with these previous investigations is
that it is unclear whether the patients were being treated with ART, as many studies do not
discuss the treatment status of patients. In regards to the monkey SIV data, early studies
showed abnormal motor behavior in SIV-infected monkeys, and delayed latencies in
brainstem auditory-evoked potentials (Fox et al. 2000). Such behavioral aberrations in basic
motor function were widely replicated (Cheney et al. 2008), and numerous studies have
shown aberrant motor-evoked potentials in SIV-infected monkeys (Raymond et al. 1998,
1999, 2000). Thus, the current findings are broadly consistent with studies of motor function
in the SIV monkey model of neuroAIDS, and neurophysiological data using EEG in HIV-
infected patients.
Previous functional and structural neuroimaging studies have improved understanding of the
neural underpinnings of HAND, but prior to the current investigation no functional imaging
study had examined motor control or general motor function in HIV-infected patients.
However, one high-resolution, whole-brain, structural imaging study did report reduced
cortical thickness throughout the primary motor and somatosensory cortices, the SMA, and
premotor areas in HIV-infected patients (Thompson et al. 2005). Thus, the functional
abnormalities observed here were not completely unexpected. In regards to previous MEG
studies, only two have investigated patients with HIV/AIDS. One reported abnormal mutual
information between MEG sensors in the anterior right part of the helmet and those in the
posterior left part. Measures of mutual information are thought to reflect connectivity, thus
these findings suggest abnormal functional connectivity between right frontal regions and
left posterior areas in HIV patients (Becker et al., 2012a). However, caution is warranted as
sensor-level MEG data (i.e., magnetic field strength measurements) contains neural activity
from a mix of many different brain areas, and it is tenuous to link such activity to specific
brain regions. Another relevant MEG study examined measurement reliability, and provided
preliminary evidence that broadband sensor-level data had good test-retest reliability after
~24 weeks in both HIV-infected patients and uninfected controls (Becker et al. 2012b). Such
findings are strongly supportive of using MEG methods to develop biomarkers for the early
identification of HAND, and the current study also makes important contributions to this
long-term goal.
In summary, we evaluated whole-brain neurophysiological activity using MEG in HIV-
infected participants and a group of uninfected controls who were performing a finger-
tapping task. Our primary findings were that infected patients have abnormal activation in
the right DLPFC, medial prefrontal, bilateral primary motor cortices, and the SMA. HIV-
infected patients had stronger responses in the right DLPFC and medial prefrontal areas, and
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the amplitude of this activity correlated with neuropsychological performance on the Trail
Making Test – B, which is generally considered a measure of psychomotor speed. In
contrast, HIV-infected patients had weaker activation in the SMA and primary motor
cortices, and the amplitude of these responses correlated with performance on the Grooved
Pegboard Test, which is an assessment of fine motor control. Lastly, the current study is not
without limitations. All of our patients were undergoing combination antiretroviral therapy,
and the effects of therapy on the MEG signal are unknown. In addition, some of our patients
had a history of drug or alcohol use, which may have a long-term impact on cortical
physiology that is not directly related to HIV. We also studied only older adults, and our
findings cannot be directly generalized to younger patients who have been infected for a
shorter period of time. Finally, our sample size was rather small compared to previous fMRI
studies, although it is comparable to many MEG studies in psychiatry and neurology. Future
studies should use larger samples and evaluate the effects of antiretroviral treatment and
infection duration.
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Experimental Paradigm. (A) Participants fixated on the central cross hair as the red dot
moved clockwise toward the two blue dots, displacing each green dot in turn. Participants
were instructed to make one finger-tap movement when the red dot was within the blue area,
but only one movement per revolution. Each revolution took approximately 6 s. (B) The
temporal onset of finger-tap responses were determined using a laser system. Essentially,
finger movement interrupted a laser-beam that extended across a narrow groove, with the
groove functioning as the finger landing area for the completion of each tap. This disruption
of the laser beam was registered by the MEG system and synced with the neural data.
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Beta Event-Related Desynchronizations (ERD) in Each Group. Statistical parametric maps
(SPMs) showed strong beta ERD responses in the left precentral gyrus of each group,
extending posterior to include areas of the postcentral gyrus. In healthy controls, strong ERD
responses were also apparent in the supplementary motor area (SMA) and the right
precentral gyrus, whereas HIV-infected patients had significant beta responses in the medial
prefrontal cortices (not shown). All images are shown in neurological convention (Left =
Left) and have been thresholded at (p < 0.001, cluster-corrected).
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Group Differences in Beta ERD Activity. Uninfected controls exhibited significantly
stronger responses compared with HIV-infected patients (blue areas; p < 0.01, cluster-
corrected) in the left precentral gyrus, SMA, and a small area of the right precentral gyrus
(not shown). In contrast, significantly greater beta ERD responses were detected in the right
dorsolateral prefrontal cortices (DLPFC), medial prefrontal cortices, and the left inferior
frontal gyrus of HIV-infected patients relative to controls (orange areas; p < 0.01, cluster-
corrected). All images are shown in neurological convention.
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Correlation of Neuropsychological Assessments and Beta ERD Amplitude. Correlation
between raw scores on the Grooved Pegboard Test (dominant hand; x-axis) and the
amplitude of beta ERD responses (y-axis) in the left precentral gyrus, SMA, left inferior
frontal gyrus, right dorsolateral prefrontal cortices, and the medial prefrontal area in HIV-
infected patients (top left). As shown, there was a significant positive correlation between
Grooved Pegboard scores and activity in the left precentral gyrus and SMA (p < 0.01, two-
tailed). Below, correlations between the amplitude of beta ERD responses (y-axis) and the
raw scores on the Trail Making Test – Part A (left) and Part B (right) are shown. There was
a significant positive correlation between performance on the Trail Making Test – A and
beta ERD in the left inferior frontal gyrus (p < 0.05, two-tailed) and marginally in the right
DLPFC (p < 0.10, two-tailed). Likewise, there was a significant positive correlation between
Trail Making Test – B scores and activity in the dorsolateral prefrontal cortices (p < 0.01,
two-tailed) and the medial prefrontal cortices (p < 0.05, two-tailed) in HIV-infected patients.
The color legend appears on the top right.
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